相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes
Aline H. de Nooijer et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial
Eli Mansour et al.
TRIALS (2021)
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
Pascal Urwyler et al.
TRIALS (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung
Alan E. Mast et al.
ELIFE (2021)
Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State
Nicholas Peoples et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection
Alpay Medetalibeyoglu et al.
INFECTION GENETICS AND EVOLUTION (2021)
Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state
Brandon Michael Henry et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani et al.
LANCET (2021)
The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury
Mineia Alessandra Scaranello Malaquias et al.
TRANSLATIONAL RESEARCH (2021)
Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
Gyorgy Sinkovits et al.
FRONTIERS IN IMMUNOLOGY (2021)
Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease
Nicholas R. Medjeral-Thomas et al.
FRONTIERS IN IMMUNOLOGY (2021)
Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation
Hanna Englert et al.
EBIOMEDICINE (2021)
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection
Lina Ma et al.
SCIENCE IMMUNOLOGY (2021)
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care
Clemens Gutmann et al.
NATURE COMMUNICATIONS (2021)
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients
Stephanie Bibert et al.
FRONTIERS IN IMMUNOLOGY (2021)
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
Youssif M. Ali et al.
FRONTIERS IN IMMUNOLOGY (2021)
Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study
Diebold Matthias et al.
SWISS MEDICAL WEEKLY (2021)
Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness
William Bain et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
Bo Shen et al.
CELL (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia
Davide Colombi et al.
RADIOLOGY (2020)
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Cynthia Magro et al.
TRANSLATIONAL RESEARCH (2020)
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
Jia Yu et al.
BLOOD (2020)
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
Vijendra Ramlall et al.
NATURE MEDICINE (2020)
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Jan C. Holter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients
Oskar Eriksson et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases
Severin Vogt et al.
FRONTIERS IN IMMUNOLOGY (2020)
Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
Pascal Urwyler et al.
FRONTIERS IN IMMUNOLOGY (2020)
Herpes simplex encephalitis in adult patients with MASP-2 deficiency
Stephanie Bibert et al.
PLOS PATHOGENS (2019)
C-Type Lectin Receptors in Antiviral Immunity and Viral Escape
Marta Bermejo-Jambrina et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Lectin Pathway of Complement in Myocardial ischemia/Reperfusion injury-Review of its Significance and the Potential impact of Therapeutic interference by C1 esterase inhibitor
Anneza Panagiotou et al.
FRONTIERS IN IMMUNOLOGY (2018)
Active Human Complement Reduces the Zika Virus Load via Formation of the Membrane-Attack Complex
Britta Schiela et al.
FRONTIERS IN IMMUNOLOGY (2018)
Collectins, H-ficolin and LL-37 reduce influence viral replication in human monocytes and modulate virus-induced cytokine production
Mitchell R. White et al.
INNATE IMMUNITY (2017)
Functional polymorphisms of the CCL2 and MBL genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection
Xinyi Tu et al.
JOURNAL OF INFECTION (2015)
Toward a structure-based comprehension of the lectin pathway of complement
Troels R. Kjaer et al.
MOLECULAR IMMUNOLOGY (2013)
C1-esterase inhibitor infusion increases survival rates for patients with sepsis
Anton A. Igonin et al.
CRITICAL CARE MEDICINE (2012)
Human H-Ficolin Inhibits Replication of Seasonal and Pandemic Influenza A Viruses
Anamika Verma et al.
JOURNAL OF IMMUNOLOGY (2012)
A Single Asparagine-Linked Glycosylation Site of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Facilitates Inhibition by Mannose-Binding Lectin through Multiple Mechanisms
Yanchen Zhou et al.
JOURNAL OF VIROLOGY (2010)
Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection
Yan Wang et al.
BMC INFECTIOUS DISEASES (2009)
Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen)
Tina Hummelshoj et al.
MOLECULAR IMMUNOLOGY (2008)
C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation
Laszlo Beinrohr et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Mannose-binding lectin and its genetic variants
P Garred et al.
GENES AND IMMUNITY (2006)
Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection
HX Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection
WKE Ip et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Interaction of C1q and mannan-binding lectin with viruses
NM Thielens et al.
IMMUNOBIOLOGY (2002)
Advances in immunology: Complement (Second of two parts).
MJ Walport
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Advances in immunology: Complement (First of two parts).
MJ Walport
NEW ENGLAND JOURNAL OF MEDICINE (2001)